SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.98+1.1%Nov 5 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (4913)11/9/2001 7:27:27 PM
From: keokalani'nui  Read Replies (2) of 52153
 
It looks like all is being saved for presentation, same with natrecor and integrillin. One problem is that the Index is horrible and the distribution of similar science is widespread and incomprehensible, and lots of corporate sponsors who did not put their name in author line.

Alexion data is exactly as represented by CEO. I, the English major, pushed around some numbers and I think it looks solid for what is says. All now depends on P3 endpoints. If they are enzymatic and death, worth a fling imo. No doubt in my mind about the correlation between high ckmb and both morbidity and mortality. Hope the audience draws the same conclusion. (I feel like a spammer, but is my honest opinion after rough look at state of the art.)

Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News